10/2/2012

A study involving almost 190,000 girls and women ages 9 to 26 found no new safety concerns with Merck & Co.'s human papillomavirus vaccine Gardasil. Fainting and rare cases of skin infections, the only observed side effects, were expected and benign, according to researchers. The findings appear in the Archives of Pediatrics & Adolescent Medicine.

Full Story:
Reuters

Related Summaries